
|Articles|December 30, 2011
Dr. Bruce Cree Discusses Multiple Sclerosis Therapy in a Case Management Setting
Advertisement
In this segment, Dr. Bruce Cree, Assistant Professor of Clinical Neurology, Department of Neurology, University of California San Francisco, discusses how he determines the most appropriate medications for his patients, and working with third-party payers.
Deciding which treatment is selected is based upon tolerability and patent preference. It is important to give patient's different treatment options available in managed care plans. Dr. Cree addresses the potential harm of using third-party preferred medications.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
Evolocumab Cuts Death Risk for a First Heart Attack or Stroke
3
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
4
NFL Dementia Deaths Often Miss Neurodegenerative Diagnosis
5




